Generic drug pricing – is it becoming a runaway train?

E-ISSN： 1931-2253|26|22|5-5

ISSN： 0959-6682

Source： PRESCRIBER, Vol.26, Iss.22, 2015-11, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Originator and generic medicine: pricing and market share

By Smit Eon van der Merwe Bredenkamp Jhandré

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 7, Iss. 2, 2013-06 ,pp. : 104-119

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Pioneering advantage in generic drug competition

By Yu Yu Gupta Sachin

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 8, Iss. 2, 2014-05 ,pp. : 126-150

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Generic drug approval: A US perspective

By Nagori B.P. Mathur V. Garg S.

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 541-545

Informa Healthcare

Access to resources Recommend Favorite

OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS

International Journal of Technology Assessment in Health Care, Vol. 32, Iss. 6, 2017-01 ,pp. : 385-392

Cambridge University Press

Access to resources Recommend Favorite

Corrigendum: Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 5, 2013-05 ,pp. : 451-451

John Wiley & Sons Inc

Access to resources Recommend Favorite